Professional background
Dr Satyen Gohil specialises in treating patients with Chronic Lymphocytic Leukaemia (CLL) and the full range of lymphoma diagnoses. He leads a number of clinical trials for these conditions and is an active member of the CLL and lymphoma research community. He has an interest in rarer haematological conditions including HLH, castleman’s disease and histiocytic disorders.
He is a core member of the HLH (haemophagocytic lymphohistiocytosis) multidisciplinary team (MDT) that provides national advice. He also runs the UCLH histiocytosis clinic, providing regional care for patients with rare histiocytic disorders such as langerhans cell histiocytosis and erdheim-chester disease.
Research interests
Dr Gohil undertook a PhD developing novel immune therapies for cancer at UCLH before spending two years at the Dana Farber Cancer Institute in Boston, USA, undertaking translational research into the tumour microenvironment, clonal evolution, and response and resistance to CAR-T cell therapy in lymphoproliferative disorders.
He is an active clinical researcher and has links with laboratory groups to help develop translational research across his research interests.
Languages spoken
Gujarati
Publications
- A list of research publications can be found here.